Hoedemaker Carlijn, van Egmond Sylvia, Sinclair Rodney
Department of Dermatology, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia.
Australas J Dermatol. 2007 Feb;48(1):43-5. doi: 10.1111/j.1440-0960.2007.00332.x.
A 53-year-old woman with clinical evidence of female pattern hair loss and histological evidence of androgenetic alopecia was initially treated with the oral antiandrogen spironolactone 200 mg daily. Serial scalp photography documented hair regrowth at 12 months; however, the hair regrowth plateaued, and at 24 months there had been no further improvement in hair density. Twice daily therapy with topical minoxidil 5% solution was then introduced and further regrowth documented, confirming the additive effect of combination therapy.
一名53岁女性,有女性型脱发的临床证据及雄激素性脱发的组织学证据,最初接受每日口服抗雄激素药物螺内酯200毫克的治疗。连续头皮摄影记录了12个月时的头发生长情况;然而,头发生长趋于平稳,到24个月时头发密度没有进一步改善。随后采用每日两次外用5%米诺地尔溶液治疗,记录到头发生进一步生长,证实了联合治疗的累加效应。